Skip to main content
. Author manuscript; available in PMC: 2010 Jun 9.
Published in final edited form as: Cancer Prev Res (Phila). 2008 Nov;1(6):413–423. doi: 10.1158/1940-6207.CAPR-08-0121

Table 2.

Lesions that reached statistical significance in both early and late stages of progression.

Lesion type [Chromosome] (location and range in ± 0.5MB)
Gain [8] (145.5); [10] (73.5)
Loss [1] (186.6); [3] (59.8~60.8); [4] (33.9); [9]
(9.0~12.1, 20.5~25.0, 28.5~30.5, 44.5); [10] (68.0);
[11] (38.5); [12] (28.3); [16] (77.3); [18] (64.9);
[20] (22.0)
LOH [3] (59.8 ~ 60.8); [9] (0.5 ~ 38.1); [16] (77.3)